Clinical Trials Logo

Clinical Trial Summary

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Adrenal Insufficiency
  • Arrythmia
  • Asthma in Children
  • Attention Deficit Disorder with Hyperactivity
  • Attention Deficit Hyperactivity Disorder
  • Blood Coagulation Disorders
  • Bronchopulmonary Dysplasia
  • Coagulation Disorder
  • Communicable Diseases
  • Coronavirus Infection (COVID-19)
  • Coronavirus Infections
  • Down Syndrome
  • Edema
  • Fibrinolysis; Hemorrhage
  • Heart Failure
  • Hemophilia
  • Hemorrhage
  • Hemostatic Disorders
  • Hyperaldosteronism
  • Hyperphosphatemia
  • Hypertension
  • Hypokalemia
  • Infections
  • Insomnia
  • Kawasaki Disease
  • Menorrhagia
  • Mucocutaneous Lymph Node Syndrome
  • Multisystem Inflammatory Syndrome in Children (MIS-C)
  • Pain
  • Pneumonia
  • Primary Hyperaldosteronism
  • Pulmonary Arterial Hypertension
  • Skin Infection
  • Syndrome
  • Urinary Tract Infections
  • Urinary Tract Infections in Children

NCT number NCT04278404
Study type Observational
Source Duke University
Contact Chi Hornik
Phone (919) 260-7626
Email chi.hornik@duke.edu
Status Recruiting
Phase
Start date March 5, 2020
Completion date July 2024

See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A